CoRegen Inc.
Sonal Kothari-Gupta, MD, PhD, currently serves as the Chief Medical Officer at CoRegen Inc. since June 2025. Prior to this role, Kothari-Gupta was the Senior Vice President and Head of Clinical Development at AffyImmune Therapeutics from April 2022 to June 2025, focusing on clinical development and regulatory strategies for autologous CAR T cell trials in aggressive solid tumors. Kothari-Gupta has held various leadership positions in notable companies, including Head of Translational Medicine at AVROBIO and Senior Director of Translational Research at Rubius Therapeutics, contributing expertise in rare cancers, gene therapy, and innovative trial design. Kothari-Gupta's academic background includes a PhD in Oncology and Cancer Biology from the University of Bradford and an MD from South Gujarat University.
Previous companies
This person is not in any teams
This person is not in any offices
CoRegen Inc.
CoRegen is leveraging its groundbreaking master gene regulator platform to develop a broad range of therapeutics capable of controlling numerous genes throughout the body, with lead indications in solid tumors.